High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.

about

Antimicrobial Stewardship Intervention and Feedback to Infectious Disease Specialists: A Case Study in High-Dose Daptomycin.Endotipsitis: A case report with a literature review on an emerging prosthetic related infection.

P2860

Q36683458-FB560B0B-8C40-4D0D-BB86-58CDCD96DF4E Q38417929-598CDF61-204D-42FB-86E6-67E0ACD6D77D

P2860

High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.

Item

http://www.wikidata.org/entity/Q40441550

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

High-dose daptomycin monothera ...... ilure of conventional therapy.

@en

type

Item

label

High-dose daptomycin monothera ...... ilure of conventional therapy.

@en

prefLabel

High-dose daptomycin monothera ...... ilure of conventional therapy.

@en

P1476

High-dose daptomycin monothera ...... ailure of conventional therapy

@en

P2093

Ian C J W Bowler

http://www.w3.org/2001/XMLSchema#string

Jane Collier

http://www.w3.org/2001/XMLSchema#string

P2860

Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature.

Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension.

Biofilm in implant infections: its production and regulation.

β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.

Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.

Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocar

Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.

P31

scholarly article

case report

P356

10.1136/BCR-2013-009529

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Scarborough

Julia M Colston

P577

2013-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23595199

http://www.w3.org/2001/XMLSchema#string

P932

3645644

http://www.w3.org/2001/XMLSchema#string

High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.

about

P2860

P2860

High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P478

P50

P577

P698

P932